You are here:  » Home   » News  


deutschdeutsch
Flash-Player installieren
ScheBo-MediaBox



» Flash-Player installieren
» Watch video in bigger size

ScheBo® · Biotech AG
Netanyastrasse 3
35394 Giessen
Germany

Phone +49 (0)641 / 4996-0
Fax +49 (0)641 / 4996-77
Email-contact

ScheBo® • Company News

AEO-Certificate
The Main Customs Office of Giessen, Germany issued an AEO-F Certificate (Authorized Economic Operator – Customs Simplifications plus Security and Safety) to ScheBo Biotech AG on September 30, 2011.

Lecture DDW 2011
Open file in new windowLecture of Prof. Dr. Sybille Mazurek on WEO/OMED Colorectal Cancer Screening Committee Meeting DDW 2011:
New molecular markers: M2-PK

ISO-Certification
Open file in new windowSuccesful ISO Re-Certification of ScheBo® • Biotech AG on 5. July 2011. Here you find the certificate!

ACB News, Issue 570, October 2010
Open file in new windowCorporate News: ScheBo Biotech and M2-PK

Science 17 September 2010, Vol. 329. no. 5998, pp. 1492 - 1499
Matthew G. Vander Heiden et. al.:
Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
» link to the abstract


Biomarker ′M2-PK′ Identified as Key Enzyme in Cancer Diagnosis and Therapy
Ground Breaking Findings on Understanding Cancer Published in the Current Issue of ′Science′:
Cancer research is facing a radical change of direction. Cancer cells do not obtain their energy from the breakdown of sugar to carbon dioxide and water, but from energy-rich intermediates of sugar metabolism instead.
» link to the article


Video from the Focus 2009 meeting
Dr. David Sanders:
Stool Tests Help Gastroenterologists

Focusing on results with faecal pancreatic elastase and faecal lactoferrin from clinical studies conducted at the Royal Hallamshire Hospital in Sheffield, Dr David Sanders discusses the clinical value of faecal diagnostic assays
» link to the video


Pharmaceutical International
Ivor Smith:
A Decade of UK Success for Schebo Biotech
» link to the article


Pharmaceutical International
René M. Kröger:
M2-PK Enzyme in Cancer Research
» link to the article


Nature 452, 230-233 (13 March 2008)
Heather R. Christofk et al.:
Pyruvate kinase M2 is a phosphotyrosine-binding protein
» link to the abstract


Nature 452, 230-233 (13 March 2008)
Heather R. Christofk et al.:
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
» link to the abstract


Castle Rauischholzhausen March 7-8, 2008
Open file in new windowSecond Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases

Veterinary Microbiology, Volume 123, Issue 4, 31-Aug-2007, S. 336-345
Schönenbrücher, H. et al.:
Detection of central nervous system tissues in meat products: Validation and standardization of a real-time PCR-based detection system
» link to the abstract


Pharmaceutical International
Leeds, John S.; Sanders, David S.:
Coeliac disease and pancreatic exocrine insufficiency
» link to the article


Alimentary Pharmacology & Therapeutics, February 2007, Volume 25, Issue 3, S. 265-271
Leeds, John S. et al.:
Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?
» link to the article


British Journal of Cancer, 2007, Volume 96, S. 1329-1334
Haug, U. et al.:
Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients
» link to the article


European Journal of Gastroenterology & Hepatology, March 2007, 9(3), S.265-276
Kumar, Y. et al.:
Tumour M2-pyruvate kinase: a gastrointestinal cancer marker
» link to the article


World Journal of Gastroenterology 2006 November 21; 12 (43)
Tonus, C.; Neupert, G.; Sellinger, M.:
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
» link to the article


38th Meeting of the European Pancreatic Club (EPC), Tampere, Finland, June 7-10, 2006
Open file in new windowEwald, N. et al.:
Prevalence of diabetis melitus secondary to pancreatic diseases (type 3c)

JPMorgan Chase Corporate Challenge in Frankfurt on 1. June 2006:
JPMorgan Chase Corporate Challenge in Frankfurt on 1. June 2006:ScheBo® • Biotech AG participated with 7 runners

13th UEGW (United European Gastroenterology Week), Copenhagen, Denmark, October 15-19, 2005
Open file in new windowEwald, N. et al.:
Pyruvate kinase M2 (Tumor M2-PK) as a screening tool for colorectal cancer (CRC)

NCRI Conference, Birmingham, UK, 2.-5. Oktober 2005
Open file in new windowMcLoughlin, R.M. et al.:
Tumour M2-PK, a novel screening tool for colorectal cancer

Pharmaceutical International
Smith, Ivor:
Faster Pancreatic Serum Test Devised by ScheBo® • Biotech
» link to the article


ASCO 41st Annual Meeting, Orlando, Florida, USA, 13.-17. Mai 2005
Open file in new windowKlör, H.U. et al.:
The tumor metabolic marker Tumor M2-PK in stool: a new biomarker for colorectal cancer

ASCO 41st Annual Meeting, Orlando, Florida, USA, 13.-17. Mai 2005
Thomas, A. et al.:
Tumor M2-Pk as predictive factor in primary systematic chemotherapy in breast cancer
» link to the article


Vet Clin Pathol. 2005; 34(1): 49-51
Open file in new windowBattersby IA, Peters IR, Day MJ, German AJ, Hall EJ.:
Effect of intestinal inflammation on fecal elastase concentration in dogs
» link to the article


Pharmaceutical International
Smith, Ivor:
Faster and Easier ScheBo® • Biotech ′Feacal Elastase Test′
» link to the article


Pharmaceutical International
Allcock, Phil:
Tumor M2 Pyruvate Kinase (Tumor M2-PK):
A Tumour Metabolic Marker for Gastrointestinal and other Cancers
» link to the article


Clinical Advances in Hematology and Oncology, October 2004
Open file in new windowClinical Symposia Report: Advances in Gastrointestinal Cancer: A Report from the World GI Congress, June 16-19, 2004, Barcelona, Spain

cancerconsultants.com, Cancer News Article, 6. Oktober 2004
Open file in new windowNew Fecal Screening Test Shows Promise in Detecting Colorectal Cancer

British Journal of Cancer, Press Release, 25. August 2004
Open file in new windowEnzyme signpost points to better colon cancer test

BBC News, 24. August 2004
Open file in new window′Better′ bowel cancer test found

washingtontimes.com, 24. August 2004
Open file in new windowGermans develop new colon cancer test

Cancer Compass, 30. Juli 2004
Open file in new windowScientists Present A New Colorectal Cancer Test, Tumour M2-PK

Abstract from the World Congress on Gastrointestinal Cancer, June 16-19, 2004, Barcelona, Spain
Open file in new windowHardt, P.D., et al:
Tumor M2-PK in Stool: A Screening Tool for Colorectal Cancer



AEO-Certificate
The Main Customs Office of Giessen, Germany issued an AEO-F Certificate (Authorized Economic Operator – Customs Simplifications plus Security and Safety) to ScheBo Biotech AG on September 30, 2011.
read...
Lecture DDW 2011: New molecular markers: M2-PK
Lecture of Prof. Dr. Sybille Mazurek on WEO/OMED Colorectal Cancer Screening Committee Meeting DDW 2011.
read...
Biomarker ′M2-PK′ Identified as Key Enzyme in Cancer Diagnosis and Therapy
Ground Breaking Findings on Understanding Cancer Published in ′Science′
read...
Video: Focus 2010 lecture on M2-PK
The high sensitivity (c.80%) and high specificity (>90%) of the M2-PK stool test for colorectal cancer screening and detection, plus benefits for patients, laboratories and doctors, was presented at Focus 2010
read...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
read...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
read...
ISO-Certificate
Our ISO-Cerficate as pdf-download.
read...